| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.04▲ | 4.89▲ | 4.90▲ | 5.12▼ | 4.68▲ |
| MA10 | 4.96▲ | 4.95▲ | 5.10▲ | 4.75▲ | 5.07▲ |
| MA20 | 4.91▲ | 5.14▼ | 5.30▼ | 4.67▲ | 5.77▼ |
| MA50 | 4.93▲ | 5.28▼ | 4.82▲ | 5.27▼ | 4.33▲ |
| MA100 | 5.15▼ | 4.80▲ | 4.64▲ | 5.88▼ | 3.21▲ |
| MA200 | 5.33▼ | 4.64▲ | 4.79▲ | 4.79▲ | 4.16▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.032▲ | -0.024▼ | -0.088▼ | 0.141▲ | -0.253▼ |
| RSI | 65.035▲ | 49.972▼ | 51.070▲ | 53.703▲ | 50.354▲ |
| STOCH | 80.963▲ | 20.569 | 16.964▼ | 60.775 | 19.384▼ |
| WILL %R | -1.695▲ | -40.000 | -52.632 | -40.217 | -69.058 |
| CCI | 151.604▲ | -8.811 | -61.788 | 79.573 | -35.537 |
|
Monday, June 01, 2026 09:05 AM
BURLINGTON, Mass., June 01, 2026 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ...
|
|
Wednesday, April 15, 2026 09:57 AM
Minerva Neurosciences (NERV) gained on Wednesday after Citizens launched its coverage with a Market Outperform recommendation, citing a blockbuster opportunity for the company’s lead candidate, ...
|
|
Wednesday, February 04, 2026 07:19 AM
The following slide deck was published by Minerva Neurosciences, Inc. in conjunction with this event.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/07/26 | 5.18 | 5.36 | 4.73 | 5.10 | 284,733 |
| 01/07/26 | 5.55 | 5.55 | 5.13 | 5.15 | 123,622 |
| 30/06/26 | 5.47 | 5.84 | 5.41 | 5.55 | 213,203 |
| 29/06/26 | 4.37 | 5.53 | 4.31 | 5.43 | 377,008 |
| 26/06/26 | 4.12 | 4.45 | 4.075 | 4.37 | 3,295,746 |
| 25/06/26 | 4.30 | 4.60 | 4.00 | 4.11 | 201,233 |
| 24/06/26 | 4.355 | 4.525 | 4.22 | 4.33 | 130,926 |
| 23/06/26 | 4.51 | 4.72 | 4.33 | 4.35 | 123,174 |
| 22/06/26 | 4.50 | 4.74 | 4.38 | 4.66 | 162,987 |
| 18/06/26 | 4.19 | 4.645 | 4.06 | 4.47 | 574,948 |
|
|
||||
|
|
||||
|
|